Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 212.00 -2.65 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.65 | 52 Week High | $160.00 | |||
| Open | $213.09 | 52 Week Low | $95.80 | |||
| Day High | $215.35 | P/E | 39.41 | |||
| Day Low | $211.49 | EPS | $5.38 | |||
| Volume | 25,295 | |||||
